Dr. Jerry Tan
Dr. Tan received his medical degree from Queen’s University in Kingston, Ontario and trained in internal medicine at the University of Toronto and in dermatology at University of British Columbia and University of Michigan. His general dermatology and aesthetic dermatology practices are in Windsor Ontario Canada. He conducts clinical trials research at Windsor Clinical Research, a clinical trials site in dermatology. Aside from industry grants, he has received research funding from the Canadian Dermatology Foundation and the National Institutes of Health Research.
Research focus includes acne, acne scars and rosacea. Additional interests include outcome measurements and informed shared decision making in dermatology. We have developed 3 patient decision aids in dermatology – acne, psoriasis and hidradenitis suppurativa – available at www.informed-decisions.org
Dr. Tan chairs the working group on clinical practice guidelines of the Canadian Dermatology Association, the rosacea international consensus group (ROSCO) and the acne core outcomes research network (ACORN). He has been an associate editor of the Journal of the American Academy of Dermatology and the British Journal of Dermatology. Over the past 3 decades, Dr. Tan has authored/co-authored more than 100 peer-reviewed publications.
Saturday NOV 13, 2021
Advances in Acne Vulgaris: Updates in topical retinoid therapy
- Describe new developments in topical retinoid treatments for acne vulgaris
- Recognize key considerations around vehicles for topical treatments in dermatology
- Integrate data on safety and efficacy of retinoids into the treatment of acne vulgaris in day-to-day practice
Summary description of the session:
Join us for an international expert panel discussion that will address new advances in topical retinoid treatment of acne vulgaris. A new formulation of a topical retinoid has been developed, incorporating recent developments in vehicle technology, to address shortcomings of older retinoid formulations. Acne experts from the US and Canada will discuss the clinical trial data, the value of this innovation, and how it fits into their day-to-day practice.
Saturday NOV 13, 2021
Racial/Ethnic Variations in Acne and the Role of Adjunct Skin Care
Racial/ethnic differences in the clinical presentation, sequelae, and desired treatment outcomes for acne have been reported. Notwithstanding limitations in the number, size, and methodologies of studies to date, the available data suggest that strategies to improve outcomes in acne patients with SOC include: Early initiation and maintenance of treatment regimens and careful consideration of tolerability of active ingredients, vehicles and dosing. Using pH balanced, non-irritating cleansers and non-comedogenic moisturizers to minimize irritation or dryness.
- Better understand the differences in acne when comparing different ethnicities;
- Discuss the challenges in treating acne in the skin of color patient;
- Review the therapeutic options in treating acne in skin of color;
- Discuss the role of moisturizers & cleansers in treating acne in skin of color;
- Explore moisturizer & cleanser ingredients offering insights into the specific role of common key ingredients in moisturizer formulations